Literature DB >> 7710351

Protective effects of melatonin in mice infected with encephalitis viruses.

D Ben-Nathan1, G J Maestroni, S Lustig, A Conti.   

Abstract

We examined the effect of the pineal neurohormone melatonin (MLT) on protection from viral encephalitis. The antiviral activity of MLT was evaluated in normal mice inoculated with Semliki Forest virus (SFV) and in stressed mice injected with the attenuated non-invasive West Nile virus (WN-25). Administration of MLT (s.c.) daily from 3 days before through 10 days after virus inoculation reduced viremia and significantly postponed the onset of disease and death by 7 to 10 days. Moreover, MLT injection reduced mortality of SFV (10 PFU) inoculated mice from 100% to 44%. In mice inoculated with high dose of SFV (100 PFU), MLT postponed death and reduced mortality by 20%. In all of the surviving mice anti-SFV antibodies were detected 22 days after virus inoculation. Infection of mice stressed by either isolation or dexamethasone injection with WN-25 induced mortality of 75% and 50% respectively, which was reduced by MLT administration to 31% and 25%, respectively. The efficiency of MLT in protecting from lethal viral infections warrants further investigations on its mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710351     DOI: 10.1007/bf01309858

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Response: virus-induced increases in plasma corticosterone.

Authors:  J E Blalock
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

2.  The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus.

Authors:  D Ben-Nathan; S Lustig; G Feuerstein
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  The influence of androgens on paralysis in mice following intravenous inoculation of herpes simplex virus.

Authors:  D L Yirrell; W A Blyth; T J Hill
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

4.  The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits.

Authors:  C J Bradish; K Allner; H B Maber
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

6.  The role of extraneural arbovirus infection in the pathogenesis of encephalitis. An electron microscopic study of Semliki Forest virus infection in mice.

Authors:  F A Murphy; A K Harrison; W K Collin
Journal:  Lab Invest       Date:  1970-04       Impact factor: 5.662

7.  Arboviral infection of voluntary striated muscles.

Authors:  P M Grimley; R M Friedman
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

8.  Interactions between the gonadal steroids and the immune system.

Authors:  C J Grossman
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

9.  The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties.

Authors:  G J Maestroni; A Conti
Journal:  J Neuroimmunol       Date:  1990-07       Impact factor: 3.478

10.  Psychoneuroendocrine influences on immunocompetence and neoplasia.

Authors:  V Riley
Journal:  Science       Date:  1981-06-05       Impact factor: 47.728

View more
  30 in total

1.  Exposure to 2500 lux increases serum melatonin in Venezuelan equine encephalomyelitis.

Authors:  S Medina; N Valero-Fuenmayor; L Chacín-Bonilla; F Añez; D Giraldoth; J Arias; G Espina; A Y Achong; E Bonilla
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

Review 4.  Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang
Journal:  Antiviral Res       Date:  2013-09-19       Impact factor: 5.970

5.  Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83.

Authors:  B Negrette; E Bonilla; N Valero; H Pons; J Garcia Tamayo; L Chacín-Bonilla; S Medina-Leendertz; F Añez
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

6.  Spike activity of neurons in the lateral hypothalamus in rats during microiontophoretic application of melatonin and noradrenaline.

Authors:  S S Pertsov; A F Meshcheryakov; R G Glushkov; K V Sudakov
Journal:  Neurosci Behav Physiol       Date:  2004-06

7.  Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Authors:  Milagros Montiel; Ernesto Bonilla; Nereida Valero; Jesús Mosquera; Luz M Espina; Yasmir Quiroz; Melchor Álvarez-Mon
Journal:  Antivir Chem Chemother       Date:  2016-08-08

8.  Aging and oxygen toxicity: Relation to changes in melatonin.

Authors:  R J Reiter
Journal:  Age (Omaha)       Date:  1997-10

9.  Intervention in the aging immune system: Influence of dietary restriction, dehydroepiandrosterone, melatonin, and exercise.

Authors:  M A Pahlavani
Journal:  Age (Omaha)       Date:  1998-10

10.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.